Guizhou Yibai Pharmaceutical Co Ltd Class A 600594
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3.41
- Day Range
- ¥3.40–3.58
- 52-Week Range
- ¥2.76–6.15
- Bid/Ask
- ¥3.57 / ¥3.57
- Market Cap
- ¥2.82 Bil
- Volume/Avg
- 12.7 Mil / 8.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.08
- Dividend Yield (Trailing)
- 1.94%
- Dividend Yield (Forward)
- 1.94%
- Total Yield
- 1.94%
Company Profile
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5,509
- Website
- http://www.gzcci.com
Comparables
Valuation
|
Metric
|
600594
|
002864
|
600557
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 23.40 | 16.50 |
Price/Book Value | 0.99 | 1.66 | 1.52 |
Price/Sales | 1.08 | 2.71 | 1.68 |
Price/Cash Flow | 12.57 | 15.94 | 10.81 |
Price/Earnings
600594
002864
600557
Financial Strength
|
Metric
|
600594
|
002864
|
600557
|
|---|---|---|---|
Quick Ratio | 1.21 | 3.66 | 2.10 |
Current Ratio | 1.82 | 3.89 | 2.50 |
Interest Coverage | −3.36 | 27.93 | — |
Quick Ratio
600594
002864
600557
Profitability
|
Metric
|
600594
|
002864
|
600557
|
|---|---|---|---|
Return on Assets (Normalized) | −3.17% | 5.20% | 6.54% |
Return on Equity (Normalized) | −5.06% | 7.55% | 8.99% |
Return on Invested Capital (Normalized) | −3.17% | 5.71% | 8.19% |
Return on Assets
600594
002864
600557
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Fkyfssdx | Grx | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Xpvnmvcn | Zvyndx | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Tkzflhdj | Fsqym | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Wchffrzx | Ptqz | $19.0 Bil | |||
| Viatris Inc
VTRS
| Ctjkwjr | Fycj | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pyjqpqtl | Tfcq | $13.4 Bil | |||
| Catalent Inc
CTLT
| Dkwmdhhrv | Zskrjn | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Lddnpjb | Jkqjlwl | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Ztbjsglht | Prrb | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Kccgykbmt | Bgxr | $2.5 Bil |
United States